{
  "schemaVersion" : 2,
  "registerId" : "F2019C00015",
  "instrumentNumber" : "61/2018",
  "citation" : "Statement of Principles concerning localised sclerosis (Reasonable Hypothesis) (No. 61 of 2018)",
  "conditionName" : "localised sclerosis",
  "effectiveFrom" : "2018-07-23",
  "standardOfProof" : "Reasonable Hypothesis",
  "icdCodes" : [ {
    "version" : "ICD-10-AM",
    "code" : "L94.0"
  }, {
    "version" : "ICD-10-AM",
    "code" : "L94.1"
  } ],
  "onsetFactors" : [ {
    "paragraph" : "9(1)",
    "text" : "inhaling respirable crystalline silica dust, at the time material\r\ncontaining crystalline silica was being:\r\n(a) produced;\r\n(b) excavated;\r\n(c) drilled, cut or ground; or\r\n(d) used in construction, manufacturing, cleaning or blasting,\r\nfor a cumulative period of at least 2 500 hours before the clinical onset\r\nof localised sclerosis",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(2)",
    "text" : "being treated with a drug or a drug from a class of drugs from the\r\nspecified list of drugs at the time of the clinical onset of localised\r\nsclerosis",
    "definedTerms" : [ {
      "term" : "specified list of drugs",
      "definition" : "means:\r\n(a) balicatib;\r\n(b) bleomycin;\r\n(c) enfuvirtide;\r\n(d) pemetrexed;\r\n(e) taxanes; or\r\n(f) tumour necrosis factor-α inhibitors."
    } ]
  }, {
    "paragraph" : "9(3)",
    "text" : "undergoing a course of therapeutic radiation for cancer, where the\r\naffected site was in the field of radiation, before the clinical onset of\r\nlocalised sclerosis",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(4)",
    "text" : "having an injury to the skin at the affected site within the six months\r\nbefore the clinical onset of localised sclerosis",
    "definedTerms" : [ {
      "term" : "injury to the skin",
      "definition" : "means any injury which is capable of causing"
    } ]
  } ],
  "aggravationFactors" : [ {
    "paragraph" : "9(5)",
    "text" : "being treated with a drug or a drug from a class of drugs from the\r\nspecified list of drugs at the time of the clinical worsening of localised\r\nsclerosis",
    "definedTerms" : [ {
      "term" : "specified list of drugs",
      "definition" : "means:\r\n(a) balicatib;\r\n(b) bleomycin;\r\n(c) enfuvirtide;\r\n(d) pemetrexed;\r\n(e) taxanes; or\r\n(f) tumour necrosis factor-α inhibitors."
    } ]
  }, {
    "paragraph" : "9(6)",
    "text" : "undergoing a course of therapeutic radiation for cancer, where the\r\naffected site was in the field of radiation, before the clinical worsening\r\nof localised sclerosis",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "9(7)",
    "text" : "inability to obtain appropriate clinical management for localised\r\nsclerosis",
    "definedTerms" : [ ]
  } ]
}